Aemetis Inc
NASDAQ:AMTX
Aemetis Inc
Aemetis, Inc. is a renewable fuels and biochemical company, which engages in the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products. The company is headquartered in Cupertino, California and currently employs 158 full-time employees. The company went IPO on 2006-06-01. The firm is focused on the acquisition, development and commercialization of negative carbon intensity products and technologies. The Company’s segments include California Ethanol, Dairy Renewable Natural Gas and India Biodiesel. The firm owns and operates approximately 65 million gallon per year ethanol production facility located in Keyes, California (Keyes Plant). In California Ethanol, the Company offers five products at the Keyes Plant: enatured fuel ethanol, wet distiller's grains (WDG), distiller's corn oil (DCO), carbon di- oxide (CO2), and condensed distillers solubles (CDS). In India Biodiesel, the Company producing two products at the Kakinada Plant: biodiesel and refined glycerin produced from further processing of the crude glycerin produced as a by product of the production of biodiesel. Its Aemetis Carbon Zero 1 facility in Riverbank, produces renewable diesel and sustainable aviation fuel.
Aemetis, Inc. is a renewable fuels and biochemical company, which engages in the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products. The company is headquartered in Cupertino, California and currently employs 158 full-time employees. The company went IPO on 2006-06-01. The firm is focused on the acquisition, development and commercialization of negative carbon intensity products and technologies. The Company’s segments include California Ethanol, Dairy Renewable Natural Gas and India Biodiesel. The firm owns and operates approximately 65 million gallon per year ethanol production facility located in Keyes, California (Keyes Plant). In California Ethanol, the Company offers five products at the Keyes Plant: enatured fuel ethanol, wet distiller's grains (WDG), distiller's corn oil (DCO), carbon di- oxide (CO2), and condensed distillers solubles (CDS). In India Biodiesel, the Company producing two products at the Kakinada Plant: biodiesel and refined glycerin produced from further processing of the crude glycerin produced as a by product of the production of biodiesel. Its Aemetis Carbon Zero 1 facility in Riverbank, produces renewable diesel and sustainable aviation fuel.
Revenue Growth: Revenue was $59.2 million, up by approximately $7 million from the previous quarter, driven by stronger biodiesel sales in India and improved ethanol pricing and production.
Biodiesel & India Expansion: India Biofuels posted $14.5 million in revenue, and the management team was strengthened to target a subsidiary IPO in early 2026.
RNG Capacity Increase: Biogas production capacity increased by more than 30% at the end of Q3, with 12 operating digesters and further expansion planned.
Tax Credit Monetization Delays: Monetization of Section 45Z production tax credits was delayed to Q4 due to timing of capacity upgrades and pending DOE guidance; $10 million in credits is in the sale process.
Debt Refinancing Plans: The company is working to refinance expensive debt, aiming for completion in the first half of 2026 as recurring tax credit revenues become clearer.
Strong Policy Tailwinds: Recent regulatory changes, including California's approval of E15 ethanol and higher LCFS credit prices, are expected to boost demand and margins.
Future Growth Expectations: Management expects multiple income streams and new projects to drive higher revenues and improved cash flow through 2026.
